FDA Inspection 713751 — Sher Institute For Reproductive Medicine New Jersey P.A.

Sher Institute For Reproductive Medicine New Jersey P.A. — FEI 3006399797

The FDA completed an inspection of Sher Institute For Reproductive Medicine New Jersey P.A. on Mar 14, 2011 in Phillipsburg, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 14, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Phillipsburg, NJ (United States)

Citations

IDCFRDescription
1222221 CFR 1271.47(a)Design of procedures to ensure compliance
1224321 CFR 1271.55(d)(1)Documentation maintained (general)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.